SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 172.26 |
| Enterprise Value ($M) | 160.40 |
| Book Value ($M) | 31.59 |
| Book Value / Share | 3.41 |
| Price / Book | 5.45 |
| NCAV ($M) | 14.83 |
| NCAV / Share | 1.60 |
| Price / NCAV | 11.61 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.18 |
| Return on Assets (ROA) | -0.10 |
| Return on Equity (ROE) | -0.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.33 |
| Current Ratio | 4.59 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 49.70 |
| Assets | 66.46 |
| Liabilities | 34.86 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 18.69 |
| Operating Income | -15.50 |
| Net Income | -6.72 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -10.46 |
| Cash from Investing | -34.32 |
| Cash from Financing | 22.92 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rosalind Advisors, Inc. | 6.92 | 1.25 | |
| 13G/A | Israel Biotech Fund II, L.P. | 10.40 | -83.22 | |
| 13G/A | Deep Insight Limited Partnership | 10.40 | -83.22 | |
| 13D/A | Access Industries Holdings LLC | 15.83 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 14,934 | 83,799 | 17.82 | |
| 6,800 | 12,366 | 54.99 | |
| 13,867 | 29,198 | 47.49 | |
| 6,892 | 16,824 | 40.97 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LUMO – Lumos Pharma, Inc. | LXEO – Lexeo Therapeutics, Inc. |
| MACK – Merrimack Pharmaceuticals, Inc. | MIRM – Mirum Pharmaceuticals, Inc. |
| MNKD – MannKind Corporation |
Financial data and stock pages provided by
Fintel.io